GWM
TXG icon

Geneos Wealth Management’s 10x Genomics TXG Stock Holding History

Geneos Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
7,500
+5,149
+219% +$103K ﹤0.01% 1033
2025
Q4 		$38.3K Buy
+2,351
New +$35.5K ﹤0.01% 1496
2025
Q3 		– Sell
-133
Closed -$1.54K – 3148
2025
Q2 		$1.54K Sell
133
-167
-56% -$1.52K ﹤0.01% 2878
2025
Q1 		$2.62K Buy
300
+251
+512% +$3.16K ﹤0.01% 2922
2024
Q4 		$704 Buy
+49
New +$773 ﹤0.01% 2839

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's TXG Position: Q1 2026 in Review

Geneos Wealth Management increased its 10x Genomics (TXG) stake by 219% in Q1 2026, buying an estimated $103K and bringing the position to 7,500 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Geneos Wealth Management first reported a position in TXG in Q4 2024 and has held it in 5 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Geneos Wealth Management held 7,500 shares of 10x Genomics worth $159K as of Q1 2026.
  • Geneos Wealth Management bought 5,149 10x Genomics shares in Q1 2026, an estimated $103K.
  • 10x Genomics made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1033 holding.
  • Geneos Wealth Management first reported a position in 10x Genomics in Q4 2024 and has held it in 5 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.